← Filings of LITE
Tables in the 10-Q of Lumentum Holdings Inc.
53 tables with numbers, filed Nov 8, 2022. Each one downloads as a CSV for Excel or
Google Sheets, with the filing's address in the last row. Only the layout is tidied (a "$" or ")" in a cell of its own is joined to its number); no value is changed.
Open the filing on sec.gov ↗
Table 1 after “es of common stock outstanding.”
Download CSV
| TABLE OF CONTENTS | | | |
| Page | | |
| PART I - FINANCIAL INFORMATION | | | |
| Item 1. | Financial Statements (Unaudited) | |
| | Condensed Consolidated Statements of Operations for the Three Months Ended October 1, 2022 and October 2, 2021 | 2 |
| | Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three Months Ended October 1, 2022 and October 2, 2021 | 3 |
| | Condensed Consolidated Balance Sheets as of October 1, 2022 and July 2, 2022 | 4 |
| | Condensed Consolidated Statements of Stockholders’ Equity for the Three Months Ended October 1, 2022 and October 2, 2021 | 5 |
First 8 of 19 rows. The CSV has all of them.
| Three Months Ended | | |
| October 1, 2022 | October 2, 2021 | |
| Net revenue | $506.8 | | $448.4 |
| Cost of sales | 282.6 | | 200.4 |
| Amortization of acquired developed intangibles | 23.0 | | 15.8 |
| Gross profit | 201.2 | | 232.2 |
| Operating expenses: | | | |
| Research and development | 72.7 | | 54.1 |
First 8 of 23 rows. The CSV has all of them.
| Three Months Ended | | |
| October 1, 2022 | October 2, 2021 | |
| Net income (loss) | $(0.4) | | $81.5 |
| Other comprehensive income (loss), net of tax: | | | |
| Net change in unrealized gain (loss) on available-for-sale securities | (0.6) | | 0.3 |
| Other comprehensive income (loss), net of tax | (0.6) | | 0.3 |
| Comprehensive income (loss), net of tax | $(1.0) | | $81.8 |
| October 1, 2022 | July 2, 2022 | |
| ASSETS | | | |
| Current assets: | | | |
| Cash and cash equivalents | $605.3 | | $1,290.2 |
| Short-term investments | 1,019.6 | | 1,258.8 |
| Accounts receivable, net | 340.5 | | 262.0 |
| Inventories | 366.2 | | 250.1 |
| Prepayments and other current assets | 106.8 | | 78.1 |
First 8 of 38 rows. The CSV has all of them.
| Common Stock | Additional Paid-In Capital | Accumulated Deficit | | Accumulated Other Comprehensive Loss | | Total Stockholders' Equity | | | |
| | Shares | Amount | | | | | | | |
| Balance as of July 2, 2022 | | 68.0 | | $0.1 | | $2,003.6 | | $(129.1) | $0.4 | $1,875.0 |
| Cumulative adjustment from adoption of ASU 2020-06 | | — | | — | | (426.5) | | 85.6 | — | (340.9) |
| Net loss | | — | | — | | — | | (0.4) | — | (0.4) |
| Other comprehensive loss | | — | | — | | — | | — | (0.6) | (0.6) |
| Issuance of shares in connection with vesting of restricted stock units and performance stock units | | 0.7 | | — | | — | | — | — | — |
| Withholding taxes related to net share settlement of restricted stock units | | (0.2) | | — | | (22.4) | | — | — | (22.4) |
First 8 of 11 rows. The CSV has all of them.
| Common Stock | Additional Paid-In Capital | Retained Earnings | | Accumulated Other Comprehensive Income | | Total Stockholders' Equity | | | | |
| | Shares | Amount | | | | | | | | |
| Balance as of July 3, 2021 | | 73.0 | | $0.1 | | $1,743.6 | | $220.9 | $8.2 | | $1,972.8 |
| Net income | | — | | — | | — | | 81.5 | | 81.5 | |
| Other comprehensive income | | — | | — | | — | | — | 0.3 | | 0.3 |
| Issuance of shares in connection with vesting of restricted stock units and performance stock units | | 0.6 | | — | | — | | — | — | | — |
| Withholding taxes related to net share settlement of restricted stock units | | (0.2) | | — | | (16.6) | | — | — | | (16.6) |
| Repurchases of common stock | | (1.1) | | — | | — | | (91.7) | — | | (91.7) |
First 8 of 10 rows. The CSV has all of them.
| Three Months Ended | | |
| October 1, 2022 | October 2, 2021 | |
| OPERATING ACTIVITIES: | | | |
| Net income (loss) | $(0.4) | | 81.5 |
| Adjustments to reconcile net income to net cash provided by operating activities: | | | |
| Depreciation expense | 24.5 | | 20.4 |
| Stock-based compensation | 46.6 | | 24.8 |
| Amortization of acquired intangibles | 32.2 | | 21.4 |
First 8 of 47 rows. The CSV has all of them.
| Short Term Debt - 2024 Notes | Long Term Debt - 2026 Notes | | Long Term Debt - 2028 Notes | Additional Paid-In Capital | Accumulated Deficit | | Deferred Tax Asset (Liability), net | | |
| Balances pre-adoption of ASC 2020-06 | $409.9 | | $831.4 | | $634.7 | | $2,003.6 | | $129.1 | $12.9 |
| Reclassify amounts from equity to debt | — | | 312.9 | | 229.3 | | (542.2) | | — | — |
| Adjustment for interest accretion | — | | (99.5) | | (9.7) | | — | | (109.2) | — |
| Tax effect | — | | — | | — | | 115.7 | | 23.6 | 92.1 |
| Balances upon adoption of ASC 2020-06 | $409.9 | | $1,044.8 | | $854.3 | | $1,577.1 | | $43.5 | $105.0 |
| Three Months Ended | | |
| October 1, 2022 | October 2, 2021 | |
| Numerator: | | | |
| Net income (loss) - basic and diluted | $(0.4) | | $81.5 |
| Denominator: | | | |
| Weighted average common shares outstanding - basic | 68.1 | | 72.7 |
| Effect of dilutive securities from 2015 Equity Incentive Plan | — | | 0.6 |
| Shares issuable assuming conversion of the convertible notes | — | | 2.1 |
First 8 of 12 rows. The CSV has all of them.
| Fair Value |
| Cash consideration for outstanding NeoPhotonics common stock (1) | $867.3 |
| Settlement of pre-existing relationship (loan to NeoPhotonics) (2) | 50.0 |
| Share-based compensation (3) | 17.1 |
| Total purchase price consideration | $934.4 |
| Fair Value |
| Total purchase price consideration | $934.4 |
| Assets acquired | |
| Cash and cash equivalents | $92.9 |
| Accounts receivable, net | 66.5 |
| Inventories | 85.3 |
| Prepayments and other current assets | 24.2 |
| Property, plant and equipment, net | 106.6 |
First 8 of 23 rows. The CSV has all of them.
| Three Months Ended | | |
| October 1, 2022 | October 2, 2021 | |
| Net revenue | $530.7 | | $532.1 |
| Net income | 32.4 | | 22.2 |
| Amortized Cost | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | |
| October 1, 2022: | | | | | | | | |
| Cash | $326.9 | | $— | | | $— | | $326.9 |
| Cash equivalents: | | | | | | | | |
| Commercial paper | 24.5 | | — | | | — | | 24.5 |
| Money market funds | 221.1 | | — | | | — | | 221.1 |
| U.S. Agency securities | 9.0 | | — | | | — | | 9.0 |
| U.S. Treasury securities | 23.8 | | — | | | — | | 23.8 |
First 8 of 33 rows. The CSV has all of them.
| Fair Value | Unrealized Losses | |
| October 1, 2022: | | | |
| U.S. Agency securities | $86.4 | | (1.8) |
| Certificates of deposit | 6.4 | | — |
| Commercial paper | 90.2 | | (0.4) |
| Corporate debt securities | 334.4 | | (5.0) |
| U.S. government bonds | 262.5 | | (3.7) |
| Total | $779.9 | | $(10.9) |
First 8 of 16 rows. The CSV has all of them.
| October 1, 2022 | July 2, 2022 | | | | |
| Amortized Cost | Fair Value | | Amortized Cost | Fair Value | |
| Due in 1 year | $831.3 | | $821.2 | | $1,010.9 | $1,002.2 |
| Due in 1 year through 5 years | 202.2 | | 198.4 | | 261.0 | 256.6 |
| $1,033.5 | | $1,019.6 | | $1,271.9 | $1,258.8 |
| Level 1 | Level 2 | | Level 3 | Total | |
| October 1, 2022: (1) | | | | | | |
| Assets: | | | | | | |
| Cash equivalents: | | | | | | |
| Commercial paper | $— | | $24.5 | | $— | $24.5 |
| Money market funds | 221.1 | | — | | — | 221.1 |
| U.S. Agency securities | — | | 9.0 | | — | 9.0 |
| U.S. Treasury securities | 23.8 | | — | | — | 23.8 |
First 8 of 16 rows. The CSV has all of them.
| Level 1 | Level 2 | | Level 3 | Total | |
| July 2, 2022: (1) | | | | | | |
| Assets: | | | | | | |
| Cash equivalents: | | | | | | |
| Commercial paper | $— | | $23.6 | | $— | $23.6 |
| Money market funds | 1,000.2 | | — | | — | 1,000.2 |
| U.S. Agency securities | — | | 8.0 | | — | 8.0 |
| U.S. Treasury securities | 22.5 | | — | | — | 22.5 |
First 8 of 16 rows. The CSV has all of them.
| October 1, 2022 | July 2, 2022 | | | | |
| Carrying Amount | Estimated Fair Value | | Carrying Amount | Estimated Fair Value | |
| 2028 Notes | $854.5 | | $691.4 | | $634.7 | $735.7 |
| 2026 Notes | 1,045.0 | | 983.8 | | 831.4 | 1,065.0 |
| 2024 Notes | 415.2 | | 553.9 | | 409.9 | 614.2 |
| $2,314.7 | | $2,229.1 | | $1,876.0 | $2,414.9 |
| October 1, 2022 | July 2, 2022 | |
| Raw materials and purchased parts | $150.6 | | $98.9 |
| Work in process | 133.3 | | 92.2 |
| Finished goods | 82.3 | | 59.0 |
| Inventories | $366.2 | | $250.1 |
| October 1, 2022 | July 2, 2022 | |
| Operating lease right-of-use assets | $120.7 | | $102.1 |
| Less: accumulated amortization | (31.3) | | (28.5) |
| Operating lease right-of-use assets, net | $89.4 | | $73.6 |
| October 1, 2022 | July 2, 2022 | |
| Land | $63.3 | | $49.7 |
| Buildings and improvement | 142.7 | | 105.3 |
| Machinery and equipment | 614.4 | | 548.8 |
| Computer equipment and software | 35.5 | | 31.3 |
| Furniture and fixtures | 9.7 | | 8.9 |
| Leasehold improvements | 44.6 | | 35.7 |
| Construction in progress | 56.4 | | 47.0 |
First 8 of 11 rows. The CSV has all of them.
| October 1, 2022 | July 2, 2022 | |
| Restructuring accrual and related charges (1) | $3.1 | | $— |
| Warranty accrual | 10.1 | | 10.0 |
| Income tax payable (2) | 27.0 | | 26.0 |
| Other current liabilities | 8.1 | | 3.4 |
| Other current liabilities | $48.3 | | $39.4 |
| October 1, 2022 | July 2, 2022 | |
| Asset retirement obligations | $8.0 | | $4.6 |
| Pension and related accrual (1) | 9.4 | | 7.7 |
| Unrecognized tax benefit | 50.9 | | 30.5 |
| Other non-current liabilities | 7.6 | | 0.1 |
| Other non-current liabilities | $75.9 | | $42.9 |
| Optical Communications | Commercial Lasers | | Total | |
| Balance as of July 2, 2022 | $363.5 | | $5.4 | | $368.9 |
| Acquisition of NeoPhotonics | 318.3 | | — | | 318.3 |
| Acquisition of IPG Photonics’ Telecom Transmission Product Lines | 6.5 | | — | | 6.5 |
| Balance as of October 1, 2022 | $688.3 | | $5.4 | | $693.7 |
| Preliminary fair value at the acquisition date | Weighted average amortization period (in years) | | | | |
| NeoPhotonics | IPG product lines | | Total acquired | | |
| Acquired developed technologies | $220.0 | | $8.6 | | $228.6 | 5.2 |
| Customer relationships | 144.5 | | 2.3 | | 146.8 | 5.9 |
| In-process research and development | 48.0 | | 29.1 | | 77.1 | n/a |
| $412.5 | | $40.0 | | $452.5 | |
| October 1, 2022 | Gross Carrying Amounts | Accumulated Amortization | | Net Carrying Amounts | Weighted average remaining amortization period (years) | |
| Acquired developed technologies | $618.9 | | $(327.0) | | $291.9 | 4.9 |
| Customer relationships | 291.8 | | (84.8) | | 207.0 | 5.5 |
| In-process research and development | 77.1 | | — | | 77.1 | n/a |
| Total intangible assets | $987.8 | | $(411.8) | | $576.0 | |
| July 2, 2022 | Gross Carrying Amounts | Accumulated Amortization | | Net Carrying Amounts | Weighted average remaining amortization period (years) | |
| Acquired developed technologies | $390.3 | | $(303.6) | | $86.7 | 2.5 |
| Customer relationships | 145.0 | | (76.0) | | 69.0 | 4.4 |
| Total intangible assets | $535.3 | | $(379.6) | | $155.7 | |
| Three Months Ended | | |
| October 1, 2022 | October 2, 2021 | |
| Cost of sales | $22.9 | | $15.8 |
| Selling, general and administrative | 9.3 | | 5.6 |
| Total amortization of intangibles | $32.2 | | $21.4 |
| Fiscal Years | |
| Remainder of 2023 | $93.6 |
| 2024 | 110.2 |
| 2025 | 97.3 |
| 2026 | 84.9 |
| 2027 | 73.0 |
| Thereafter | 39.9 |
| Total future amortization | $498.9 |
| Liability component: | October 1, 2022 | July 2, 2022 | | | | | | | | |
| 2024 Notes (1) | 2026 Notes (2) | | 2028 Notes (3) | 2024 Notes (1) | 2026 Notes (2) | | 2028 Notes (3) | | |
| Principal | $448.1 | | $1,050.0 | | $861.0 | | $448.1 | | $1,050.0 | $861.0 |
| Unamortized debt discount and issuance costs | (32.9) | | (5.0) | | (6.5) | | (38.2) | | (218.6) | (226.3) |
| Net carrying amount of the liability component | $415.2 | | $1,045.0 | | $854.5 | | $409.9 | | $831.4 | $634.7 |
| Three Months Ended | | |
| October 1, 2022 | October 2, 2021 | |
| Contractual interest expense | $2.7 | | $1.6 |
| Amortization of the debt discount and debt issuance costs | 5.7 | | 15.3 |
| Total interest expense | $8.4 | | $16.9 |
| Fiscal Years | 2024 Notes | 2026 Notes | | 2028 Notes | Total | |
| Remainder of 2023 | $0.6 | | $5.3 | | $4.3 | $10.2 |
| 2024 | 449.2 | | 5.3 | | 4.3 | 458.8 |
| 2025 | — | | 5.3 | | 4.3 | 9.6 |
| 2026 | — | | 5.3 | | 4.3 | 9.6 |
| 2027 | — | | 1,052.4 | | 869.6 | 1,922.0 |
| Total convertible notes payments | $449.8 | | $1,073.6 | | $886.8 | $2,410.2 |
| Foreign currency translation adjustments, net of tax (1) | Defined benefit obligations, net of tax (2) | | Unrealized gain (loss) on available-for-sale securities, net of tax | | Total | |
| Beginning balance as of July 2, 2022 | $9.7 | | $1.0 | | $(10.3) | | $0.4 |
| Other comprehensive loss | — | | — | | (0.6) | | (0.6) |
| Ending balance as of October 1, 2022 | 9.7 | | 1.0 | | (10.9) | | (0.2) |
| Foreign currency translation adjustments, net of tax (1) | Defined benefit obligations, net of tax (2) | | Unrealized gain (loss) on available-for-sale securities, net of tax | | Total | |
| Beginning balance as of July 3, 2021 | $9.7 | | $(1.4) | | $(0.1) | | $8.2 |
| Other comprehensive income | — | | — | | 0.3 | | 0.3 |
| Ending balance as of October 2, 2021 | 9.7 | | (1.4) | | 0.2 | | 8.5 |
| Three Months Ended | | |
| October 1, 2022 | October 2, 2021 | |
| Balance as of beginning of period | $— | | $5.7 |
| Charges (reversals), net | 9.3 | | (1.1) |
| Payments | (6.2) | | (3.8) |
| Balance as of end of period | $3.1 | | $0.8 |
| Three Months Ended | | |
| October 1, 2022 | October 2, 2021 | |
| Cost of sales | $5.5 | | $4.6 |
| Research and development | 9.6 | | 5.0 |
| Selling, general and administrative | 31.5 | | 15.2 |
| Total stock-based compensation | $46.6 | | $24.8 |
| Three Months Ended | | |
| October 1, 2022 | October 2, 2021 | |
| Income tax benefit associated with stock-based compensation | $5.1 | | $4.0 |
| Restricted Stock Units | Performance Stock Units | | | | | | |
| | | Number of Shares | Weighted-Average Grant Date Fair Value per Share | | Number of Shares | Weighted-Average Grant Date Fair Value per Share | |
| Balance as of July 2, 2022 | | | 2.0 | | $85.9 | | 0.3 | $81.9 |
| Replacement Awards Issued | | | 0.4 | | 93.4 | | — | — |
| Granted | | | 1.5 | | 89.2 | | 0.5 | 88.3 |
| Vested | | | (0.5) | | 81.7 | | (0.1) | 68.8 |
| Canceled | | | (0.1) | | 85.0 | | — | 82.6 |
| Balance as of October 1, 2022 | | | 3.3 | | $88.9 | | 0.7 | $89.3 |
| Awards Available for Grant |
| Balance as of July 2, 2022 | 3.8 |
| Assumed in connection with NeoPhotonics merger | 0.4 |
| Replacement Awards | (0.4) |
| Granted | (2.0) |
| Canceled | 0.1 |
| Balance as of October 1, 2022 | 1.9 |
| Three Months Ended | | |
| October 1, 2022 | October 2, 2021 | |
| Balance as of beginning of period | $10.0 | | $5.0 |
| Warranties assumed in NeoPhotonics merger | 0.7 | | — |
| Provision for warranty | 1.5 | | 1.7 |
| Utilization of reserve | (2.1) | | (1.6) |
| Balance as of end of period | $10.1 | | $5.1 |
| Three Months Ended | | |
| October 1, 2022 | October 2, 2021 | |
| Net revenue: | | | |
| OpComms | $453.4 | | $406.0 |
| Lasers | 53.4 | | 42.4 |
| Net revenue | $506.8 | | $448.4 |
| Gross profit: | | | |
| OpComms | $216.0 | | $225.9 |
First 8 of 16 rows. The CSV has all of them.
Table 41 after “(in millions, except percentage data):”
Download CSV
| Three Months Ended | | | | | | |
| October 1, 2022 | October 2, 2021 | | | | | |
| Amount | % of Total | | Amount | | % of Total | |
| Net revenue: | | | | | | | |
| Americas: | | | | | | | |
| United States | $62.2 | | 12.3% | | | $28.1 | 6.3% |
| Other Americas | 59.8 | | 11.8 | | | 35.0 | 7.8 |
| Total Americas | $122.0 | | 24.1% | | | $63.1 | 14.1% |
First 8 of 16 rows. The CSV has all of them.
| October 1, 2022 | July 2, 2022 | |
| Property, plant and equipment, net | | | |
| United States | $136.9 | | $107.8 |
| Thailand | 118.0 | | 107.6 |
| Japan | 89.2 | | 38.9 |
| China | 58.4 | | 32.7 |
| Other countries | 75.5 | | 73.5 |
| Total property, plant and equipment, net | $478.0 | | $360.5 |
| Three Months Ended | | | | |
| October 1, 2022 | October 2, 2021 | | | |
| OpComms: | | | | | |
| Telecom and Datacom | $360.1 | 71.1% | | $216.0 | 48.2% |
| Industrial and Consumer | 93.3 | 18.4 | | 190.0 | 42.3% |
| Total OpComms | $453.4 | 89.5% | | $406.0 | 90.5% |
| Lasers | 53.4 | 10.5% | | 42.4 | 9.5% |
| Net Revenue | $506.8 | | $448.4 | | |
| Contract balances | Balance sheet location | October 1, 2022 | July 2, 2022 | | Change | Percentage Change | |
| Accounts receivable, net | Accounts receivable, net | $340.5 | | $262.0 | | $78.5 | 30.0% |
| Deferred revenue and customer deposits | Other current liabilities | $1.1 | | $— | | $1.1 | n/a |
Table 45 after “The results of operations for the periods presented are not necessarily indicative of results to be expected for future periods. The followi”
Download CSV
| Three Months Ended | | |
| October 1, 2022 | October 2, 2021 | |
| Segment net revenue: | | | |
| OpComms | 89.5% | | 90.5% |
| Lasers | 10.5 | | 9.5 |
| Net revenue | 100.0 | | 100.0 |
| Cost of sales | 55.8 | | 44.7 |
| Amortization of acquired developed intangibles | 4.5 | | 3.5 |
First 8 of 20 rows. The CSV has all of them.
| Three Months Ended | | | | | |
| October 1, 2022 | October 2, 2021 | | Change | Percentage Change | |
| Segment net revenue: | | | | | | |
| OpComms | $453.4 | | $406.0 | | $47.4 | 11.7% |
| Lasers | 53.4 | | 42.4 | | 11.0 | 25.9 |
| Net revenue | $506.8 | | $448.4 | | $58.4 | 13.0% |
| Gross profit | $201.2 | | $232.2 | | $(31.0) | (13.4)% |
| Gross margin | 39.7% | | 51.8% | | | |
First 8 of 14 rows. The CSV has all of them.
| Three Months Ended | | | | | | |
| October 1, 2022 | October 2, 2021 | | | | | |
| Amount | % of Total | | Amount | | % of Total | |
| Americas: | | | | | | | |
| United States | $62.2 | | 12.3% | | | $28.1 | 6.3% |
| Other Americas | 59.8 | | 11.8 | | | 35.0 | 7.8 |
| Total Americas | $122.0 | | 24.1% | | | $63.1 | 14.1% |
| Asia-Pacific: | | | | | | | |
First 8 of 15 rows. The CSV has all of them.
| Three Months Ended | | | | | |
| Gross Profit | Gross Margin | | | | |
| October 1, 2022 | October 2, 2021 | | October 1, 2022 | October 2, 2021 | |
| OpComms | $216.0 | | $225.9 | | 47.6% | 55.6% |
| Lasers | 28.1 | | 20.8 | | 52.6% | 49.1% |
| Segment total | $244.1 | | $246.7 | | 48.2% | 55.0% |
| Unallocated corporate items: | | | | | | |
| Stock-based compensation | (5.5) | | (4.6) | | | |
First 8 of 12 rows. The CSV has all of them.
| Three Months Ended | | |
| October 1, 2022 | October 2, 2021 | |
| Foreign exchange gains (losses), net | $9.0 | | $(0.1) |
| Interest and investment income | 4.8 | | 0.6 |
| Other income (expense), net | — | | 0.1 |
| Total other income (expense), net | $13.8 | | $0.6 |
| (in millions) | Three Months Ended | | |
| October 1, 2022 | October 2, 2021 | |
| Provision for income taxes | $19.2 | | $18.1 |
| Payments due by period | | | | |
| Total | Less than 1 year | | More than 1 year | |
| Contractual Obligations | | | | | |
| Asset retirement obligations | $8.0 | | $0.5 | | $7.5 |
| Operating lease liabilities, including imputed interest (1) | 77.9 | | 15.1 | | 62.8 |
| Pension plan contributions (2) | 1.4 | | 1.4 | | — |
| Purchase obligations (3) | 416.2 | | 374.1 | | 42.1 |
| Term loans | 4.9 | | 4.9 | | — |
First 8 of 11 rows. The CSV has all of them.
| Period | Total number of shares purchased (1) | Average price paid per share (2) | | Total number of shares purchased as part of publicly announced plans or programs | | Maximum number (or approximation dollar value) of shares that may yet be purchased under the plans or programs | | |
| July 3, 2022 to July 30, 2022 | — | | $— | | | — | | $410.2 |
| July 31, 2022 to September 3, 2022 | 286,710 | | $89.80 | | | 286,710 | | $384.5 |
| September 4, 2022 to October 1, 2022 | — | | | | | | | |
| Total | 286,710 | | | | 286,710 | | $384.5 | |
Table 53 after “The following exhibits are filed herewith or are incorporated by reference to exhibits previously filed with the Securities and Exchange Com”
Download CSV
| Exhibit | | Incorporated by Reference | | | | Filed |
| No. | Exhibit Description | Form | File No. | Exhibit | Filing Date | Herewith |
| 2.1 | Agreement and Plan of Merger by and among Lumentum Holdings Inc., Neptune Merger Sub, Inc. and NeoPhotonics Corporation, dated as of November 3, 2021 | 8-K | 001-36861 | 2.1 | November 5, 2021 | |
| 10.1 | NeoPhotonics Corporation - Amended and Restated 2020 Equity Incentive Plan | S-8 | 333-238938 | 99.1 | June 10, 2021 | |
| 10.2 | NeoPhotonics Corporation - 2010 Equity Incentive Plan, as amended | S-8 | 333-189577 | 99.1 | June 25, 2013 | |
| 10.3 | NeoPhotonics Corporation - 2011 Inducement Award Plan | S-8 | 333-177306 | 99.1 | October 13, 2011 | |
| 31.1 | Certification of the Chief Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | | | | | X |
| 31.2 | Certification of the Chief Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | | | | | X |
First 8 of 12 rows. The CSV has all of them.